Prognostic Indicators for Recurrent Symptoms After a Single Corticosteroid Injection for Carpal Tunnel Syndrome
Conclusions:
A single injection achieved symptom relief in 79% of patients at six weeks; these results were maintained in 31% of patients at twelve months. Diabetic patients were at higher risk of symptom recurrence.
Level of Evidence:
Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
Source: The Journal of Bone and Joint Surgery - Category: Orthopaedics Authors: Blazar, P. E., Floyd, W. E., Han, C. H., Rozental, T. D., Earp, B. E. Tags: Hand & Wrist Scientific Articles Source Type: research
More News: Carpal Tunnel Syndrome | Corticosteroid Therapy | Diabetes | Endocrinology | Orthopaedics | Study